Cellular substrates of p34(cdc2) and its companion cyclin-dependent kinases - PubMed (original) (raw)
Cellular substrates of p34(cdc2) and its companion cyclin-dependent kinases
E A Nigg. Trends Cell Biol. 1993 Sep.
Abstract
Cyclin-dependent kinase (cdks) are key components of the engine that drives the cell proliferation cycle in all eukaryotes. These kinases are related to p34(cdc2) and associate with regulatory subunits belonging to the cyclin family. To understand how cdks promote cell cycle progression, it will be important to identify their physiological substrates and to determine how phosphorylation influences the functions of these substrates. This article discusses recent progress as well as some of the problems related to the quest for cdk substrates.
Similar articles
- Phosphorylation of the p34 subunit of human single-stranded-DNA-binding protein in cyclin A-activated G1 extracts is catalyzed by cdk-cyclin A complex and DNA-dependent protein kinase.
Pan ZQ, Amin AA, Gibbs E, Niu H, Hurwitz J. Pan ZQ, et al. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8343-7. doi: 10.1073/pnas.91.18.8343. Proc Natl Acad Sci U S A. 1994. PMID: 8078885 Free PMC article. - A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.
Palmer A, Gavin AC, Nebreda AR. Palmer A, et al. EMBO J. 1998 Sep 1;17(17):5037-47. doi: 10.1093/emboj/17.17.5037. EMBO J. 1998. PMID: 9724639 Free PMC article. - Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates.
Suryadinata R, Sadowski M, Sarcevic B. Suryadinata R, et al. Biosci Rep. 2010 Mar 17;30(4):243-55. doi: 10.1042/BSR20090171. Biosci Rep. 2010. PMID: 20337599 Review. - Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases.
Hirai H, Kawanishi N, Iwasawa Y. Hirai H, et al. Curr Top Med Chem. 2005;5(2):167-79. doi: 10.2174/1568026053507688. Curr Top Med Chem. 2005. PMID: 15853645 Review.
Cited by
- PLK-1 regulates MEX-1 polarization in the C. elegans zygote.
Kim AJ, Miller SI, Greiner EC, Kettenbach AN, Griffin EE. Kim AJ, et al. bioRxiv [Preprint]. 2024 Jul 26:2024.07.26.605193. doi: 10.1101/2024.07.26.605193. bioRxiv. 2024. PMID: 39091813 Free PMC article. Preprint. - ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation.
Xiao Y, Chen Y, Chen J, Dong J. Xiao Y, et al. Cancers (Basel). 2023 Nov 15;15(22):5424. doi: 10.3390/cancers15225424. Cancers (Basel). 2023. PMID: 38001686 Free PMC article. - MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer.
Zeng Y, Yin L, Zhou J, Zeng R, Xiao Y, Black AR, Hu T, Singh PK, Yin F, Batra SK, Yu F, Chen Y, Dong J. Zeng Y, et al. Oncogene. 2022 Jul;41(31):3859-3875. doi: 10.1038/s41388-022-02399-3. Epub 2022 Jul 2. Oncogene. 2022. PMID: 35780183 Free PMC article. - The phosphatase CTDSPL2 is phosphorylated in mitosis and a target for restraining tumor growth and motility in pancreatic cancer.
Xiao Y, Chen Y, Peng A, Dong J. Xiao Y, et al. Cancer Lett. 2022 Feb 1;526:53-65. doi: 10.1016/j.canlet.2021.11.018. Epub 2021 Nov 20. Cancer Lett. 2022. PMID: 34813892 Free PMC article. - Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.
Yin L, Zeng Y, Zeng R, Chen Y, Wang TL, Rodabaugh KJ, Yu F, Natarajan A, Karpf AR, Dong J. Yin L, et al. Oncogene. 2021 Dec;40(50):6772-6785. doi: 10.1038/s41388-021-02117-5. Epub 2021 Nov 19. Oncogene. 2021. PMID: 34799660 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous